Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2025)

Vanda Pharmaceuticals' Exchange Rate Effect history spans 9 years, with the latest figure at $20000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 109.9% year-over-year to $20000.0; the TTM value through Dec 2025 reached $23000.0, up 114.11%, while the annual FY2025 figure was $23000.0, 114.11% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $20000.0 at Vanda Pharmaceuticals, up from -$180000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $183000.0 in Q4 2022 and bottomed at -$202000.0 in Q4 2024.
  • The 5-year median for Exchange Rate Effect is $3000.0 (2021), against an average of $4050.0.
  • The largest annual shift saw Exchange Rate Effect plummeted 941.67% in 2021 before it soared 993.33% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$101000.0 in 2021, then surged by 281.19% to $183000.0 in 2022, then decreased by 18.03% to $150000.0 in 2023, then tumbled by 234.67% to -$202000.0 in 2024, then surged by 109.9% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Exchange Rate Effect are $20000.0 (Q4 2025), -$180000.0 (Q3 2025), and $134000.0 (Q2 2025).